Censavudine (INN; development code BMS-986001 in Bristol Myers-Squibb, OBP-601 in Oncolys Biopharma Inc. and TPN-101 in Transposon Therapuetics, Inc. ) is an investigational new drug being developed by Bristol Myers-Squibb for the treatment of HIV infection.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.